PROTO SCRIPT PHARMACEUTICAL CORP Retained Earnings
PROTO SCRIPT PHARMACEUTICAL CORP had Retained Earnings of -$8.74 million as of 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2018-03-08
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$8.74M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$8.46M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$8.12M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$7.62M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2017-09-30 | -$8.74M 10-Q · filed 2018-03-08 | |
| 2017-06-30 | -$8.46M 10-Q · filed 2018-01-17 | |
| 2017-03-31 | -$8.12M 10-Q · filed 2017-11-22 | |
| 2016-12-31 | -$7.62M 10-Q · filed 2018-03-08 | |
| 2016-09-30 | -$352.61K 10-Q · filed 2017-01-06 | |
| 2016-06-30 | $50.94K 10-Q · filed 2016-11-18 | |
| 2016-05-31 | -$186.36K 10-K · filed 2016-08-19 | |
| 2016-02-29 | -$165.71K 10-Q · filed 2016-06-13 | |
| 2015-12-31 | -$237.76K 10-K/A · filed 2017-10-19 | $29.19K 10-Q · filed 2016-11-18 |
| 2015-11-30 | -$163.88K 10-Q · filed 2016-06-13 | |
| 2015-08-31 | -$156.27K 10-Q · filed 2016-06-13 | |
| 2015-05-31 | -$153.22K 10-K · filed 2016-08-19 | |
| 2015-02-28 | -$143.93K 10-Q · filed 2015-04-20 | |
| 2014-11-30 | -$137.32K 10-Q · filed 2015-01-20 | |
| 2014-08-31 | -$114.69K 10-Q · filed 2014-10-20 | |
| 2014-05-31 | -$108.04K 10-K · filed 2016-05-24 | |
| 2013-05-31 | -$69.78K 10-K · filed 2014-10-09 |